ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 227 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $20,678,000 | +16.1% | 1,263,930 | 0.0% | 1.16% | +3.1% |
| Q2 2022 | $17,809,000 | -41.8% | 1,263,930 | 0.0% | 1.13% | -28.2% |
| Q1 2022 | $30,574,000 | +608.1% | 1,263,930 | +583.2% | 1.57% | +835.1% |
| Q4 2021 | $4,318,000 | -71.7% | 185,000 | -50.0% | 0.17% | -68.1% |
| Q3 2020 | $15,263,000 | -14.9% | 370,000 | 0.0% | 0.53% | -33.1% |
| Q2 2020 | $17,934,000 | +14.7% | 370,000 | 0.0% | 0.79% | -26.0% |
| Q1 2020 | $15,633,000 | – | 370,000 | – | 1.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |